Activation of coagulation and hyperfibrinolysis in patients with aortic arch atheromatosis (Aortic AA) as a risk factor for cerebral ischemia

Summary

In patients with cerebral ischemia, a frequent finding is atheromatous plaques in the ascending aorta and the aortic arch. Since we were able to demonstrate that patients with atrial fibrillation have an increased coagulatory activity, we wanted to evaluate a potential systemic activation of the coagulatory system in patients with aortic arch atheromatosis (Aortic AA). In 134 consecutive patients, we determined several parameters of the co-agulatory and fibrinolytic systems as well as several thrombophilia risk factors and compared the results with 134 age- and sex-matched healthy controls. In 90 of the 134 patients, transesophageal echocardiography showed Aortic AA, and in the remaining 44 patients, there were no aortic findings. The Aortic AA group showed higher concentrations of thrombin-antithrombin (TAT) and plasmin-antiplasmin complexes (PAP). Further division into 4 subgroups of different severity (grade I: no plaques; grade II: plaques 2–5 mm, grade III: plaques > 5 mm, grade IV: mobile plaques), revealed increasing concentrations of fibrinogen, D-dimers and tissue-type plasminogen activator. The grade IV-group displayed the highest values in comparison to all other groups. In conclusion, Aortic AA as such is a risk factor for cerebral ischemia. It causes a systemically detectable activation of coagulation which substantially exceeds the values for controls. This observation is in accordance with our findings in patients with atrial fibrillation.

Keywords

Activation of coagulation - hypercoagulability - aortic arch atheromatosis - cerebral ischemia

• References

• 1 Kronzon I, Tunick PA. Atheromatous disease of the thoracic aorta: pathologic and clinical implications. Ann Intern Med 1997; 126: 629-37.
• 2 Fischer CM. Occlusion of the internal carotid artery. Arch Neurol Psych 1951; 65: 346-77.
• 3 Tunick PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol 2000; 35: 545-54.
• 4 Khatibzadeh M, Mitusch R, Stierle U. et al. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996; 27: 664-9.
• 5 Mitusch R, Stierle U, Tepe C. et al. Systemic embolism in aortic arch atheromatosis. Eur Heart J 1994; 15: 1373-80.
• 6 Tunick PA, Culliford AT, Lamparello PJ. et al. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli [see comments]. Ann Intern Med 1991; 114: 391-2.
• 7 Kronzon I, Tunick PA. Transesophageal echocardiography as a tool in the evaluation of patients with embolic disorders. Prog Cardiovasc Dis 1993; 36: 39-60.
• 8 Bauer KA, Rosenberg RD. Activation markers of coagulation. Baillieres Clin Haematol 1994; 7: 523-40.
• 9 Mitusch R, Siemens HJ, Garbe M. et al. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996; 5: 219-23.
• 10 Ribakove GH, Katz ES, Galloway AC. et al. Surgical implications of transesophageal echocardiography to grade the atheromatous aortic arch. Ann Thorac Surg 1992; 53: 758-61.
• 11 Jespersen J, Bertina RM, Haverkate F. Laboratory techniques on thrombosis – a manual. Dordrecht, The Netherlands: Kluwer Academic Publisher; 1999: 1
• 12 Wiseman JD, Bessman JD, Calam RR. et al. Procedures for the collection of diagnostic blood specimens by venipuncture: approved standard (H3-A4). NCCLS coagulation collection 1998; 18: 1-40.
• 13 Calam RR, Benoit SW, Foreback CC. Procedures for the handling and processing of blood specimens: approved guideline (H18-A). NCCLS coagulation collection 1990; 10: 1-22.
• 14 Motulsky H, Nonparametric ANOVA. in AnonymousIntuitive Biostatistics. New York: Oxford University Press; 1995: 260-1
• 15 Witteman JC, Kannel WB, Wolf PA. et al. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 1990; 66: 1060-4.
• 16 Toyoda K, Yasaka M, Nagata S. et al. Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke 1992; 23: 1056-61.
• 17 Pearson AC, Labovitz AJ, Tatineni S. et al. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991; 17: 66-72.
• 18 Nihoyannopoulos P, Joshi J, Athanasopoulos G. et al. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol 1993; 71: 1208-12.
• 19 Vaduganathan P, Ewton A, Nagueh SF. et al. Pathologic correlates of aortic plaques, thrombi and mobile „aortic debris“ imaged in vivo with transesophageal echocardiography. J Am Coll Cardiol 1997; 30: 357-63.
• 20 Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.